0001209191-19-058699.txt : 20191203 0001209191-19-058699.hdr.sgml : 20191203 20191203162046 ACCESSION NUMBER: 0001209191-19-058699 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191129 FILED AS OF DATE: 20191203 DATE AS OF CHANGE: 20191203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Flannelly Barry P CENTRAL INDEX KEY: 0001615842 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 191266022 MAIL ADDRESS: STREET 1: ROUTE 141 AND HENRY CLAY ROAD CITY: WILMINGTON STATE: DE ZIP: 19880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-11-29 0 0000879169 INCYTE CORP INCY 0001615842 Flannelly Barry P 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 EVP & General Manager US Common Stock 2019-11-29 4 M 0 600 73.21 A 17579 D Common Stock 2019-11-29 4 S 0 600 95.00 D 16979 D Common Stock 2019-12-02 4 M 0 6582 73.21 A 23561 D Common Stock 2019-12-02 4 S 0 6582 95.00 D 16979 D Non-Qualified Stock Option (right to buy) 73.21 2019-11-29 4 M 0 600 0.00 D 2022-01-07 Common Stock 600 20346 D Non-Qualified Stock Option (right to buy) 73.21 2019-12-02 4 M 0 6582 0.00 D 2022-01-07 Common Stock 6582 13764 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Includes an aggregate of 13,951 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Beginning January 8, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years /s/ Barry Flannelly 2019-12-03